Aigen Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$7.36M |
| 2 |
Boston Scientific
BSX
|
+$6.53M |
| 3 |
Aon
AON
|
+$5.83M |
| 4 |
Applied Materials
AMAT
|
+$5.65M |
| 5 |
PNC Financial Services
PNC
|
+$4.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$6.12M |
| 2 |
Ralph Lauren
RL
|
+$5.45M |
| 3 |
Medtronic
MDT
|
+$5.44M |
| 4 |
Motorola Solutions
MSI
|
+$4.42M |
| 5 |
General Dynamics
GD
|
+$4.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.65% |
| 2 | Financials | 15.11% |
| 3 | Industrials | 13.25% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Healthcare | 11.91% |
Similar funds
Aigen Investment Management's Q1 2025 Portfolio in Review
As of Q1 2025, Aigen Investment Management held 1,093 positions worth $627M, up 11% from $567M the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
Aigen Investment Management deployed $86.6M of net new capital in Q1 2025, opening 396 new positions and adding to 182 existing holdings. Its largest new stake was Boston Scientific: 64,812 shares worth $6.54M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Medtronic, an estimated $5.44M trimmed.
- Aigen Investment Management's largest Q1 2025 buy was Boston Scientific: 64,812 shares worth $6.54M.
- Aigen Investment Management added most to US Bancorp in Q1 2025, an estimated $7.36M increase.
- Aigen Investment Management's biggest Q1 2025 reduction was Medtronic, cutting an estimated $5.44M.
- Aigen Investment Management fully exited ConocoPhillips in Q1 2025, selling an estimated $6.12M.
- Aigen Investment Management's ten largest holdings make up 8.8% of its $627M portfolio in Q1 2025.
- Aigen Investment Management opened 396 new positions and closed 366 in Q1 2025.
- Aigen Investment Management's portfolio value rose 11% quarter-over-quarter to $627M.
Based on Aigen Investment Management's 13F filing for Q1 2025, filed 12 May 2025.